Andrea Tan
Stock Analyst at Goldman Sachs
(0.41)
# 2465
Out of 5,329 analysts
50
Total ratings
40.74%
Success rate
-8.01%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeut... | Maintains: Buy | 18 16 | 3.5 | 357.14% | 6 | Apr 17, 2025 | |
DAWN Day One Biopharmaceu... | Maintains: Buy | 39 27 | 7.72 | 249.74% | 6 | Mar 25, 2025 | |
TARS Tarsus Pharmaceutica... | Maintains: Neutral | 36 41 | 48.08 | -14.73% | 3 | Nov 15, 2024 | |
INSM Insmed | Maintains: Strong Buy | 74 102 | 73.09 | 39.55% | 9 | Jul 10, 2024 | |
SGMT Sagimet Biosciences | Maintains: Neutral | 23 6 | 4.04 | 48.51% | 5 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 31 | 14.43 | 114.83% | 1 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 3 2 | 0.37 | 440.54% | 3 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Sell | 2 | 4.77 | -58.07% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 17 | n/a | n/a | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 160 | 167.95 | -4.73% | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 2.52 | 852.38% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 10 4 | 1.28 | 212.5% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 178 375 | 337.52 | 11.1% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 13 | 5.64 | 130.5% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | n/a | n/a | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | 0.68 | 488.24% | 2 | May 24, 2022 |